CTTQ
Status and phase
Conditions
Treatments
About
This is an open, single-arm, multi-center clinical study designed to evaluate the efficacy and safety of TQ05105 tablets combined with TQB3909 tablets in patients with moderate- and high-risk Myelofibrosis.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
93 participants in 2 patient groups
Loading...
Central trial contact
Hong yan Tong, Doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal